Gerresheimer Ag logo

Gerresheimer Ag(ETR) GXI

Market Cap€1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-2%
5 Year-63%
1 Year+7%
1 Month+6%
€28.70
-2.65%
-0.78Today
Gerresheimer Ag last closing stock price
MetricPriceDate
Last closeEUR 29.382026-10-15
Gerresheimer Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.38%EUR 28.422026-10-08
1 month+5.68%EUR 27.802026-09-15
3 month+1.1%EUR 29.062026-07-17
Year to date+6.53%EUR 27.582025-12-30
1 year+7.46%EUR 27.342025-10-15
3 year-71.97%EUR 104.802023-10-16
5 year-63.28%EUR 80.002021-10-15
Since inception-1.99%EUR 30.082007-06-11

Gerresheimer Ag Financials at a Glance

Market Cap

€1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.28B

Net Income (TTM)

-€400.62M

EPS (TTM)

-€11.60

P/E Ratio

-2.54

Dividend

€0.00

Beta (Volatility)

0.08 (Low)

Price

€28.70

Volume

162,672

Open

€29.50

Previous Close

€28.70

Daily Range

€28.70 - €29.82

52-Week Range

€14.83 - €32.00

Estimated Earnings Date

Nov 4, 2026

GXI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gerresheimer Ag

Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in packaging solutions and sophisticated drug delivery systems. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, serving the pharmaceutical, biotech, and medical technology sectors.

Products and Services
  • Drug administration tools like inhalers and prefillable syringes
  • Glass primary packaging products for pharmaceuticals and cosmetics
  • Intelligent drug delivery systems, including micro pumps
Growth Outlook
  • Strong demand for drug delivery systems is expected to drive revenue growth
  • Expansion into emerging markets presents significant opportunities
  • Investment in R&D aims to enhance product offerings and innovation
Financial Highlights
  • Recent quarterly revenue of 474.9 million EUR, showing resilience
  • Trailing twelve months (TTM) revenue of 2.4 billion EUR indicates stability
  • Operating cash flow of 24.3 million EUR reflects operational efficiency
Gerresheimer AG is positioned in a growing market, driven by increasing healthcare demands and innovations in drug delivery systems. The company's diverse product range and commitment to research and development enhance its competitive edge. Recent financial performance, including a solid quarterly revenue figure, underscores the company's resilience in a challenging economic environment. With a focus on expanding into emerging markets and enhancing product offerings, Gerresheimer AG presents a compelling opportunity for potential investors interested in the healthcare sector.
AI Generated • Oct 12, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,301

CEO

Uwe Ferdinand Röhrhoff

Website

www.gerresheimer.com

Headquarters

Düsseldorf, NW 40468, DE

GXI Financials

Key Financial Metrics (TTM)

Gross Margin

15.28%

Operating Margin

-11.90%

Net Income Margin

-17.60%

Return on Equity

-32.84%

Return on Capital

-7.81%

Return on Assets

-9.21%

Earnings Yield

-39.37%

Dividend Yield

0.00%

Payout Ratio

-0.59%

Stock Overview

Market Cap

€1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

34.54M

Volume

162.67K

Avg. Volume

150.46K

Financials (TTM)

Gross Profit

€347.76M

Operating Income

-€270.78M

EBITDA

€238.06M

Operating Cash Flow

€261.60M

Capital Expenditure

-€253.72M

Free Cash Flow

€369.47M

Cash & ST Invst.

€167.61M

Total Debt

€2.21B

Gerresheimer Ag Performance Analysis

Gerresheimer Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30EUR 1,817,094,00021.3%
20232023-11-30EUR 1,990,486,0009.5%
20242024-11-30EUR 1,991,269,0000.0%
20252025-11-30EUR 2,320,885,00016.6%
Gerresheimer Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-05-3115.5%
Q32025-08-31-6.7%
Q42025-11-3014.1%
Q12026-02-28-25.7%
Gerresheimer Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30EUR 3.0614.7%
20232023-11-30EUR 3.4813.8%
20242024-11-30EUR 2.38-31.6%
20252025-11-30EUR -9.27N/A
Gerresheimer Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-05-31194.2%
Q32025-08-31-175.5%
Q42025-11-30-2300.0%
Q12026-02-2867.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€474.94M

-8.7%

Gross Profit

€49.26M

-61.1%

Gross Margin

10.37%

N/A

Market Cap

€1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€75.27K

N/A

Employees

13,528

N/A

Net Income

-€98.32M

-445.8%

EBITDA

€9.56M

-88.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€167.61M

-8.8%

Total Debt

€2.21B

+2.0%

Accounts Receivable

€254.47M

-24.2%

Inventory

€439.20M

-15.0%

Long Term Debt

€1.59B

+73.6%

Short Term Debt

€618.20M

-50.5%

Return on Assets

-9.21%

N/A

Return on Invested Capital

-9.27%

N/A

Free Cash Flow

-€40.01M

+92.1%

Operating Cash Flow

€24.29M

+187.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.62-0.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$103.05-6.78%
INTCIntel
$94.12-4.08%
CRWVCoreWeave
$66.94+1.76%

Questions About GXI

What is the current price of Gerresheimer Ag?

Gerresheimer Ag is trading at €28.70 per share.

What is the 52-week range for Gerresheimer Ag?

Over the past 52 weeks, Gerresheimer Ag has traded between €14.83 and €32.00.

How much debt does Gerresheimer Ag have?

As of the most recent reporting period, Gerresheimer Ag reported total debt of €2.21B.

How much cash does Gerresheimer Ag have on hand?

Gerresheimer Ag reported €167.61M in cash and cash equivalents in its most recent financial results.

What is Gerresheimer Ag’s dividend yield?

Gerresheimer Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services